Stay updated on Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial

Sign up to get notified when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the context of a Phase 3, open-label, extension study to assess the long term efficacy and safety of lirentelimab in patients with Eosinophilic Gastritis and/or Eosinophilic Duodenitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:20:31.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying requirements such as informed consent, completion of prior related studies, and specific health conditions. Previously, this section had no information provided.
    Difference
    22%
    Check dated 2024-05-22T20:31:48.000Z thumbnail image
  7. Check
    38 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map'. This change likely indicates a shift in the type of intervention or content being featured on the webpage, possibly related to medical and healthcare publications and documentation.
    Difference
    1%
    Check dated 2024-05-01T21:45:14.000Z thumbnail image

Stay in the know with updates to Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.